Last reviewed · How we verify
NCT03567512
Reducing Second-hand Smoke Exposure Among Young Children in Rural China
NA trial testing Smoking hygiene intervention in Second Hand Tobacco Smoke in 668 participants. Completed in 30 November 2019.
30 November 2019
Quick facts
| Lead sponsor | Duke Kunshan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 668 |
| Start date | 20 March 2018 |
| Primary completion | 30 November 2019 |
| Estimated completion | 30 November 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- Smoking hygiene intervention
- Placebo intervention
Conditions studied
- Second Hand Tobacco Smoke — all drugs for Second Hand Tobacco Smoke →
Sponsor
Duke Kunshan University
Who can join
18 and older, any sex, with Second Hand Tobacco Smoke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Second-hand smoking (SHS) is a health hazard to infants and children, in whom it is associated with lower respiratory tract infections, wheezing, cough, middle ear infections and sudden infant death syndrome. The high prevalence of smoking in adults in China, 52.9% among men, 2.4% among women, results in many children being exposed to SHS at home. Data on the effectiveness of evidence-based smoking hygiene intervention to reduce SHS exposure among young children (e.g., aged 5 or below) is lacking in China. Children in the rural setting are more exposed to SHS due to the lack of tobacco control policy initiative in the rural setting and the high prevalence of smoking among the rural public. In the proposed project we aim to examine the effectiveness of a protection motivation theory-based smoking hygiene intervention (SHI), delivered by community health worker (CHW) in 6 different contacts, to reduce SHS exposure among young children in two rural areas of China: Taizhou city (Zhejiang Province) and Dali city (Yunnan province). The results of this study will provide clinical evidence for the development of CHW-delivered interventions designed to reduce exposure to SHS and related morbidity and mortality among children in rural China. The successful results could also be used to draft guidelines for health promotion interventions, which could be implemented as a policy for all primary health care settings in rural China and other developing countries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03567512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Second Hand Tobacco Smoke
Currently open trials in the same condition.
- NCT06166433 — Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia · NA · recruiting
- NCT06582693 — Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Thr · NA · recruiting
- NCT06127589 — The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children from Tobacco Smoke Exposure · NA · recruiting
Other Duke Kunshan University trials
Trials by the same sponsor.
- NCT07076134 — Community-and Primary Care-based Intervention Linked With mObile Technology for HTN Control in Nepal · NA · not yet recruiting
- NCT07045363 — Embedded Community-based Heart-Age Risk Education Trial in Cinese Primary Healthcare · NA · not yet recruiting
- NCT06975501 — Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health · NA · active not recruiting
- NCT05508672 — Community-Centered eHealth Smoking Cessation Intervention(CCeSCI) · NA · completed
- NCT05792618 — Stroke Patients and Family Longitudinal Study in Rural China · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03567512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duke Kunshan University
- Last refreshed: 10 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03567512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing